Trial intelligence / Profile preview

BioMin F vs Colgate Sensitive Pro-Relief vs Sensodyne Rapid Action for Dentin Hypersensitivity

NCT04249336Phase 3Completed

Sponsor
Dow University of Health Sciences
Start
Sep 2019
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluoro-calcium-phosphosilicate in dentin hypersensitivity (DH), sponsored by Dow University of Health Sciences. Started Sep 2019; status: completed.

02

Drugs

fluoro-calcium-phosphosilicate
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT04249336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04249336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call